Genotyping for ABCG2 rs2231142, ABCB1 rs1128503 and rs2032582 polymorphism could become a clinical routine practice to select the appropriate dose to decrease the risk of sunitinib-induced thrombocytopenia and HFS in Asians while ensuring efficacy. This evidence concerns the gene ABCB1 and Hand-foot syndrome.